[Development of targeting thermosensitive liposomes for tumor treatment]
- PMID: 21800535
[Development of targeting thermosensitive liposomes for tumor treatment]
Abstract
Liposomes which offer the advantage of the enhanced drug accumulation at tumor sites are currently applied extensively in the clinical treatment of tumor. However, accumulation of the liposomes in the tumor area cannot guarantee the drug bioavailability. To resolve the question, thermosensitive targeting liposomes (TTL) have been the hotspot of current studies. TTL can enhance drug accumulation at tumor sites and be triggered to release their contents upon hyperthermia. By applying these two strategies, antitumor efficacy of encapsulated drug can be significantly improved. The present paper reviews the development of TTL in recent years.
Similar articles
-
Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors.Pharm Res. 2010 Aug;27(8):1750-4. doi: 10.1007/s11095-010-0154-2. Epub 2010 Apr 28. Pharm Res. 2010. PMID: 20424894 Free PMC article.
-
Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors.Oncol Res. 1995;7(7-8):393-8. Oncol Res. 1995. PMID: 8747602
-
Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods.ACS Nano. 2011 Jun 28;5(6):4919-26. doi: 10.1021/nn201010q. Epub 2011 Jun 2. ACS Nano. 2011. PMID: 21591812
-
Ultrasound-induced cell permeabilisation and hyperthermia: strategies for local delivery of compounds with intracellular mode of action.Int J Hyperthermia. 2012;28(4):311-9. doi: 10.3109/02656736.2012.664307. Int J Hyperthermia. 2012. PMID: 22621733 Review.
-
Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors.Expert Opin Drug Deliv. 2014 Jan;11(1):83-100. doi: 10.1517/17425247.2014.866650. Epub 2013 Dec 10. Expert Opin Drug Deliv. 2014. PMID: 24320104 Review.